News

HELSINKI — Surgeons in training can stabilize their complication rate after approximately 100 cases, according to a speaker at the European Society of Cataract and Refractive Surgeons winter meeting.“Patient safety can be easily achieved with good mentorship and a structured training program,” Nikolaos Dimitriadis, MD, resident doctor at General Hospital of Sparta, Greece, … [Read more...] about Complication rate highest in early cataract surgery training

A multicenter retrospective cohort study found a low rate of long-term ocular adverse events in children given mitogen-activated protein kinase pathway (MEK) inhibitors for cancer treatment. … [Read more...] about Ocular Adverse Events Appear to Be Rare in Children Treated With MEK Inhibitors

Even in an era of remarkable therapeutics for neovascular age-related macular degeneration, there remains a lack of therapies to improve vision in dry AMD.Many patients continue to live with central vision loss that erodes independence and quality of life.They may be “stable” anatomically, yet functionally they struggle: recognizing faces, reading mail, managing medications, … [Read more...] about Wearable vision enhancement, AI help patients with AMD

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other therapeutics represents one of the most consequential regulatory developments in drug development in decades.If implemented effectively, it will reshape how new biologic medicines reach patients and how regulators evaluate safety in the era of precision … [Read more...] about FDA’s move away from animal testing is ‘scientifically necessary’

To investigate the role of TNFRSF10A in chronic central serous chorioretinopathy (cCSCR), polypoidal choroidal vasculopathy (PCV), and neovascular age-related macular degeneration (nAMD). … [Read more...] about Associations of TNFRSF10A with Central Serous Chorioretinopathy, Polypoidal Choroidal Vasculopathy and Age-related Macular Degeneration